Wednesday, April 30, 2014

Ethics Versus Science (Final Draft of Argumentative Essay)


















Ethics Versus Scientific Progress:
The Benefits of Stem Cell Research Outweigh Risks


Zumana Miyfa
ENG 21003, Section C
Professor Nargiza Matyakubova
March 22, 2014









Ethics Versus Scientific Progress:
The Benefits of Stem Cell Research Outweigh Risks
            How can one even imagine living with an ailing disease, such as Parkinson’s, diabetes, or cancer? Well, these are only some of the illnesses that numerous individuals must deal with on a daily basis. Would it be wrong for scientists to be allowed to conduct groundbreaking research that could treat these diseases more effectively and lead to possible cures? The clear answer to this question is absolutely not. It should be permissible for researchers to conduct stem cell research because the advances made in the field of medicine outweigh the risks and ethical dilemma concerning this type of research.
What is Stem Cell Research?
            The controversial debates over stem cell research began when stem cells were first discovered in the late 1900s. According to Haldeman-Englert (2012), “A stem cell is generic cell that can make copies of itself indefinitely” (p. 1). These unique cells are fundamental for the revolutionary type of research known as “stem cell research” because they can multiply at a quick rate and create specialized cells for various types of tissues that the human body needs, such as brain tissue, heart muscle, and liver tissue. The cells can be stored away and used when specialized cells are necessary as well.
There are also two basic types of stem cells: embryonic stem cells and adult stem cells. Embryonic stem cells (ES cells) are “taken from aborted fetuses or fertilized eggs that are left over from in vitro fertilization (IVF)” (Haldeman-Englert, 2012, p. 1). The ES cells are useful for research and medical purposes because they can produce cells for almost any part of the body. On the other hand, adult stem cells are specific to certain cell types and cannot be used as effectively for conducting research. Adult stem cells can be found in both adults and children, but they consist of blood, intestine, skin, and muscle cell types (Badge, 2001, p. 85). Therefore, adult stem cells are not as versatile as embryonic stem cells, which can lead to cures for various
diseases.
            Two significant breakthroughs have emerged as a result of stem cell research, and it is necessary for further research to be conducted in order to make even more discoveries. Those breakthroughs are “animal cloning by Ian Wilmut, Keith Campbell and colleagues and the derivation of pluripotent human embryonic stem (ES) cells by Jamie Thomson and co-workers” (Badge, 2001, p. 88). Animal cloning is an advancement in stem cell research because if animals could be cloned, then there is potential for human body parts and organs to be cloned and used to cure individuals who have heart problems or kidney failure. Thomson’s discovery of pluripotent human ES cells is also essential because pluripotent embryonic stem cells are found in implanted embryos, fetuses, and developed organisms; these are the cells that have the ability to become all cell types. Therefore, his research on ES cells is the building block for future stem cell research since the pluripotent cells can form various tissues that the body needs.
Furthermore, pluripotent stem cells can reduce the human body’s natural rejection of certain cells and organs, which may occur during surgical procedures. The “combining [of the animal cloning process and pluripotent ES cells discovery] in the process of ‘therapeutic cloning’, whereby ES cells could be derived from a patient’s cell,” solves the dire “problems of immune rejection” (Badge, 2001, p. 88). Therapeutic cloning can result in the curing many diseases because the human body does not reject the cloned embryonic stem cells whereas the body often rejects cells if organs are donated from other individuals. The ES cells are also “one of the easiest types to grow [and they have] the greatest potential” (Badge, 2001, p. 89). Therefore, the embryonic stem cells are the most necessary for research because they are the ones that will be able to treat and cure cell-related illnesses.
Benefits of Stem Cell Research
            As a result of ethical dilemmas, stem cell research has been conducted primarily on mice, but ES cell research has significantly more benefits when human embryos are used. According to Solter (2006), “The derivation of the first human ES cell lines and human embryonic germ-cell lines lagged significantly behind their mouse counterparts” (p. 324). Cell research is primarily conducted on mice since it is difficult for researchers to obtain human embryos and fetuses for stem cell research due to “potential legal problems and political and moral dilemmas” (Solter, 2006, p. 324). However, in comparison to the results from the mice experiments, the experiments conducted on human ES cells have shown that the human cells are more applicable to the human body in terms of curing diseases that people contract. Therefore, ES cell research is beneficial to people because specialized cells that can be created from the stem cells have been proven to efficiently treat Parkinson’s disease.
            Embryonic stem cells can effectively treat Parkinson’s disease since the illness affects a person’s brain cells. Parkinson’s is a motor systems disorder, in which nerve cells in the brain that are supposed to produce a chemical called dopamine break down (Landis, 2012, p. 1). The absence of those nerve cells result in tremor (excessive shaking or trembling), stiff muscles, slow movement, and/or problems walking. Although there is no cure for this diseases, stem cell “tissue transplantation has shown beneficial effects on some patients by long-term reduction in clinical symptoms such as tremors, bradykinesia (slowness of movement), akinesia (absence of normal movement) and postural impairment” (Master, McLeod, and Mendez, 2007, p.4). Therefore, stem cell research directly benefits those who suffer from the incurable Parkinson’s disease by reducing the symptoms and discomfort that the illness causes and by decreasing the amount of drugs that individuals need to take to treat Parkinson’s.  
            In addition to treating Parkinson’s disease effectively, embryonic stem cell research can also lead to progress in finding the cure for cancer. Huntly and Gilliland (2005) are two researchers who have developed the theory that cancerous tumors are results of “cancer stem cells,” which are cells in the embryo or fetus that mutate and spread as tumors (p. 311). These two men noted the following:
A cancer stem cell would function in a similar way to sustain the growth and spread of tumours while repopulating the distinct cell types represented within the tumour. However, a cancer stem cell would not be subject to the same intrinsic and extrinsic controls as normal stem cells. This ‘cancer-stem-cell hypothesis’ represents a modern-day interpretation of the proposal made by pathologists such as Rudolph Virchow and Julius Cohnheim ~150 years ago that cancer results from the activation of dormant embryonic-tissue remnants. (Huntly & Gilliland, 2005, p. 311)
This quote expresses how Huntly and Gilliland expanded upon the original “cancer-stem-cell hypothesis” that Virchow and Cohnheim proposed many years ago. The prevalent theory is that tumors develop from the cells that mutate within the embryo. However, ES cell research can help determine exactly which cells would be likely to cause cancer and discover potential ways to change those cells. In terms of treating those who are battling cancer, stem cells can be implanted in order to replace the tumors that must be removed and the human body would not be as susceptible to rejecting those cells. Further research could ensure that those stem cell transplants prevent cancer from returning in the long run.
Risks of Embryonic Stem Cell Research
            One major risk of stem cell research is that it puts women’s health in danger because of the medicine they receive after donating ova. Beeson (2006) stated that, “young women are being asked to donate or sell their ova, not only for use in fertility clinics, but increasingly for non-clinical use in experimental cloning research” (p. 1). When women donate or cell their eggs for experiment research, they are given hormonal drugs that may have short-term and long-term effects on their health. However, this issue can easily be resolved through better regulation of the hormonal drugs that are administered to the ova donors. Women could also be properly advised
regarding how those drugs will affect their bodies, and the option of donating or selling ova should be determined by those women solely since they have the freedom to do what they want with their own bodies.
Ethical Dilemma Regarding Stem Cell Research
            A common misconception is that stem cell research is unethical because it goes against religious doctrines in which God or a higher power is meant to create human life. However, the utilizing of stem cells to cure illnesses does not infringe on religion at all. Scientists are not creating new life; they are simply allowing embryonic stem cells to duplicate and become specialized cells that can provide properly functioning organs and body parts to those in need. It is certainly not ethical to make it difficult for researchers to obtain embryonic stem cells since the research studies would be benefitting the greater good, and religious practice promotes helping those who are in need of aid.
            Opponents of stem cell research also argue that stem cell research promotes abortion, which is the same as destroying potential human life. However, “the person principally responsible for the experiment must also affirm his or her own knowledge of the sources of [the embryonic] tissue […] and that the researcher had no part in the abortion decision or its timing” (Shapiro, 1999, p. 31). This quote from the National Bioethics Advisory Commission explains that ES cell research does not endorse more abortions to take place because the researcher cannot have any say in the choice to have an abortion. Therefore, it is incorrect for critics to assume that stem cell research supports abortions. Embryonic stem cell research actually makes proper use of aborted fetuses, which benefits society at large.
            Another fallacy is that corporations profit more from stem cell research than actual human beings do. According to Beeson (2006), “[C]ollection of eggs for embryo cloning research is being conducted in the context of an international race for dominance in […] the production of embryonic stem cells and related products that may result in substantial private financial gain while offering no therapeutic benefits” (p. 1). In reality, embryonic stem cell research and stem cell research in general is not meant for corporations, public or private, to make financial gains. Even if businesses do make a profit off of stem cell research, the public receives the benefits in the long run; therefore, further research should be encouraged. On the contrary, corporations and the federal government should also be providing researchers with sufficient money in order to conduct further stem cell research. Therefore, the argument that ES cell studies “result in substantial private financial gain while offering no therapeutic benefits” is invalid because of the overwhelming benefits that stem cell research may provide to people.  
The Bigger Picture
            Ultimately, stem cell research leads to greater benefits for individuals and for society while causing minimal harm to women who donate their ova. The major benefits of embryonic stem cell research are that it effectively treats malignant diseases, such as Parkinson’s and cancer, and has the potential for scientists to clone the cells in order to form fully functioning organs and body parts for people who need transplants. Ethics should not deter scientists from conducting further ES cell research. In fact, the world needs more researchers and egg cell donors who are willing to contribute to innovative stem cell research and take the future of medicine into their own hands.








References
Badge, R. (2001). The Future For Stem Cell Research. In MRC National Institute for Medical
Research Publications. Retrieved from
http://www.ibt.unam.mx/computo/pdfs/cursosviejos/bcelularII02/bcelular/Nature%20414_88%20stem-rev.pdf
Beeson, D. (2006). Egg Harvesting For Stem Cell Research: Medical Risks And Ethical
Problems. In Reproductive BioMedicine Online Publications. Retrieved from
http://download.journals.elsevierhealth.com/pdfs/journals/1472-6483/PIIS1472648310606475.pdf
Halderman-Englert, C. (2012). Stem Cell Research. In University of Maryland Medical Center
Publications Online. Retrieved from
http://umm.edu/health/medical/ency/articles/stem-cell-research
Huntly, B., and Gilliland, G. (2005). Leukaemia Stem Cells And The Evolution Of Cancer-Stem-
Cell Research. In Nature Reviews: Cancer Publications and PubMed Databases.
Retrieved from
http://groups.molbiosci.northwestern.edu/mayo/Paper%20pdfs/Huntly%20et%20al%20LSC.pdf
Landis, S. C. (2012). NINDS Parkinson's Disease Information Page. In National Institute of Neurological Disorders and Stroke Publications Online. Retrieved from
http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm
Master, Z., McLeod, M., and Mendez, I. (2007). Benefits, Risks And Ethical Considerations In
Translation Of Stem Cell Research To Clinical Applications In Parkinson's Disease. In
Journal of Medical Ethics Publications. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2598267/
Shapiro, H. T. (1999). Ethical Issues in Human Stem Cell Research. Rockville, MD: National
Bioethics Advisory Commission Publications.
Solter, D. (2006). From Teratocarcinomas To Embryonic Stem Cells And Beyond: A History Of Embryonic Stem Cell Research. In Nature Reviews: Genetics Publications and PubMed Databases. Retrieved from
http://mcb5068.wustl.edu/MCB/Lecturers/Huettner/Reading%20pdf/Solter06_NatureRevGenet.pdf


No comments:

Post a Comment